Isis Pharmaceuticals, Inc.Condensed Consolidated Balance Sheets | |||||
(In Thousands) | |||||
June 30, | December 31, | ||||
2010 | 2009 | ||||
(unaudited) | |||||
| Assets: | |||||
| Cash, cash equivalents and short-term investments | $522,028 | $574,312 | |||
| Other current assets | 14,857 | 21,814 | |||
| Property, plant and equipment, net | 36,071 | 27,338 | |||
| Other assets | 33,395 | 33,720 | |||
| Total assets | $606,351 | $657,184 | |||
| Liabilities and stockholders' equity: | |||||
| Other current liabilities | $27,946 | $35,763 | |||
| Current portion of deferred contract revenue | 77,268 | 75,681 | |||
| 2 5/8% convertible subordinated notes | 128,907 | 125,100 | |||
| Long-term obligations, less current portion | 15,767 | 11,478 | |||
| Investment in Regulus Therapeutics Inc. | 4,070 | - | |||
| Long-term deferred contract revenue | 90,164 | 107,097 | |||
| Stockholders' equity | 262,229 | 302,065 | |||
| Total liabilities and stockholders' equity | $606,351 | $657,184 | |||
